A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

NCT06658834 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: Dexamethasone Combined with romiplostim N01
DRUG: Dexamethasone monotherapy

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]